FDA Approval of MS Drug Puts Ampligen Back In Play
Deja Vu? “I just try and not think about it, because it gets me furious” multiple sclerosis patient The story sounds eerily similar. Citing questions regarding study quality and side effects, the FDA refuses to approve a drug for a condition for which few...
Neuroinflammation and Chronic Pain Link Established: Authors Call for Treatment Trials
“the present findings offer clinical implications that may serve to guide future studies of the pathophysiology and management of a variety of persistent pain conditions.” Loggia et. al. Chronic pain was thought for many years to be mostly a neuronal problem. Over or...
“Pharmaceutical Grade” Low Dose Naltrexone Now Available for ME/CFS and Fibromyalgia Patients
Into the Big Leagues Low dose naltrexone (LDN) is able to do for some people with intractable pain what opioids and other drugs can’t do – reduce the pain. Those drugs have something LDN doesn’t, however, – FDA approval. You can’t prove that LDN works,...
Yes, Fibromyalgia is Real – and Here’s Why
In Pain? Symposium Suggests Immune Therapies Might Be Able to Help
It’s no secret. The medical profession is lousy at treating chronic pain. Some doctors and researchers think there’s a better way, however, and at a recent Symposium they strongly urged the medical profession to get out of its rut – and give immune...Lives Interrupted Latest Story
Allyn Archer
Atlanta, United States
Former occupation: Architect, Professor of Architecture
$2,768,291
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
